Safety and efficacy of cefpirome among Filipino patients
Philippine Journal of Internal Medicine
;
: 1-5, 2015.
Artículo
en Inglés
| WPRIM
| ID: wpr-633532
ABSTRACT
BACKGROUND:
Infectious diseases remain a significant cause of morbidity and mortality. Cefpirome, a fourth generation Cephalosporin, is a potent antibiotic against a wide variety of organisms that may be used alone or in combination with other antimicrobials to combat various infections.OBJECTIVE:
This is a post-marketing surveillance study documenting the safety and efficacy of cefpirome among Filipino patients.METHODOLOGY:
This was a multicenter, open-label, noncomparative study involving 402 patients who received at least one dose of cefpirome. Safety and efficacy data were gathered.RESULTS:
Cefpirome was used as monotherapy in majority of the cases. Pneumonia (76%) was the most frequent indication for the use of this drug. The most commonly utilized dosage regimen was 2.0 grams every 12 hours for a mean of 4.2 days. This was associated with a successful clinical outcome in almost 90% of cases. There was almost negligible side effect reported.CONCLUSION:
The use of cefpirome was shown to be safe and well-tolerated with associated successful clinical outcomes among Filipino patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neumonía
/
Cefalosporinas
/
Enfermedades Transmisibles
/
Morbilidad
/
Cefpiroma
/
Antiinfecciosos
/
Antibacterianos
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Philippine Journal of Internal Medicine
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS